Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
Haematologica|August 30, 2008
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL studyMathilde Hunault-Berger, Patrice Chevallier, Martine Delain, et al.
Skin Health and Disease|April 5, 2024
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case reportPierre Peterlin, Julia Bonnelye, Alice Garnier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2015
Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie CellulaireFlorent Malard, Noel Milpied, Didier Blaise, et al.
Bone Marrow Transplantation|May 10, 2023
Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMTFrédéric Baron, Annalisa Ruggeri, Christophe Peczynski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2020
Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector ReconstitutionDhon Roméo Makanga, Thierry Guillaume, Catherine Willem, et al.
Eclinicalmedicine|October 3, 2023
Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trialPierre Peterlin, Alice Garnier, Amandine Le Bourgeois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2019
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant CyclophosphamideCatherine Willem, Dhon Roméo Makanga, Thierry Guillaume, et al.
Human Vaccines & Immunotherapeutics|June 21, 2021
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patientsPatrice Chevallier, Soraya Saiagh, Virginie Dehame, et al.
Blood|September 3, 2017
Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 studyFlorent Malard, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Pageof 34